Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32435593
Browse in-depth TOC on "Label-Free Detection Market"
450 - Tables
54 - Figures
486 - Pages
Danaher Corporation: Leading Innovator in Label-Free Detection
Danaher Corporation, headquartered in the US, is a top player in the global label-free detection market for 2023. Through its biotechnology division, including subsidiaries Cytiva and Pall, Danaher provides a range of label-free detection products. Although the growth in infectious disease testing revenue showed a rise in 2022, it is anticipated that this trend may not continue into 2023. Nevertheless, Danaher remains committed to advancing its product offerings through substantial investments in R&D. The company also focuses on inorganic growth strategies, such as partnerships and acquisitions, to enhance its competitive edge in the label-free detection industry.
Sartorius AG: Prominent Force in Label-Free Detection
Sartorius AG, based in Germany, is a major player in the label-free detection sector. The company is dedicated to expanding its product range through robust R&D investments and strategic inorganic growth. Sartorius emphasizes product integration and user-friendly solutions to strengthen its market position. Notably, in April 2022, Sartorius launched the Octet SF3, an advanced surface plasmon resonance (SPR) system under its Octet brand. By introducing new products and focusing on comprehensive solutions, Sartorius aims to enhance its global presence in the label-free detection market.
Agilent Technologies, Inc.: Key Contributor in Label-Free Detection
Agilent Technologies, Inc., based in the US, held the third-largest market share in 2023. The company offers a diverse portfolio across life sciences, diagnostics, and applied chemical markets. Agilent's subsidiary, ACEA Biosciences, provides label-free detection products. Agilent is focused on product development and market expansion, highlighted by the February 2024 announcement of an integration between the XCELLigence RTCA HT platform and the BioTek BioSpa 8 Automated Incubator. This integration enhances throughput and reduces sample sizes by offering a label-free, non-invasive analysis of cell growth and cytotoxicity. Through such innovations, Agilent aims to capture a larger market share and compete effectively in the label-free detection industry.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=32435593
Label-Free Detection Market Segmentation: Instruments at the Forefront
In 2023, the global label-free detection market was segmented into instruments, consumables, software, and services. The instruments segment led the market, attributed to the growing use of advanced label-free detection instruments in drug discovery and clinical research studies. Technological advancements and the introduction of new, high-performance instruments by leading market players have further boosted this segment.
Technology Segmentation: Surface Plasmon Resonance Dominates
The market is segmented by technology into surface plasmon resonance (SPR), differential scanning calorimetry (DSC), bio-layer interferometry (BLI), isothermal titration calorimetry (ITC), and other label-free detection (LFD) technologies. In 2023, SPR technology held the largest market share due to the frequent introduction of advanced SPR instruments. These advancements have driven increased adoption and application across various research fields.
Application Segmentation: Binding Kinetics Leads
Applications are segmented into binding kinetics, binding thermodynamics, hit confirmation, lead generation, endogenous receptor detection, and others. Binding kinetics commanded the largest market share in 2023, reflecting its significant role in drug discovery and molecular research. The increasing use of label-free detection instruments for these applications has driven the growth of this segment.
End User Segmentation: Pharmaceutical & Biotechnology Companies Lead
The end-user segments include pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations (CROs), and other users. In 2023, pharmaceutical & biotechnology companies led the market share, driven by their extensive use of label-free detection instruments, reagents, and consumables in R&D. This is coupled with rising research activities, development of new therapeutics, and expanding healthcare infrastructure in emerging markets.
Regional Insights: North America in the Lead
Geographically, the market is divided into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America dominated the market in 2023, supported by major players, advanced biopharmaceutical infrastructure, and favorable regulatory conditions. Europe held the second-largest share, with Asia Pacific expected to exhibit the highest growth rate during the forecast period due to increasing pharmaceutical R&D, rising demand for novel detection products, significant investments by biopharmaceutical companies, and growing support for research activities.
For more information, inquire now! Inquire Now
Related Reports:
Cell Analysis Market
Proteomics Market
Cell Isolation Market
Oxidative Stress Assay Market
Cell Counting Market
Get access to the latest updates on Label Free Detection Companies and Label Free Detection Market Share
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
SOURCE MarketsandMarkets
Share this article